CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $84.00

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $84.00

CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price decreased by Citigroup from $89.00 to $84.00 in a report issued on Thursday morning, Benzinga reports. Citigroup currently has a buy rating on the stock. Several other research firms have also recently weighed in on CRSP. TheStreet upgraded shares of CRISPR Therapeutics from a d+ […]

Related Keywords

, Samarth Kulkarni , Raju Prasad , Avoro Capital Advisors , Therapeutics Company Profile , Investment Management , Barclays , Securities Exchange Commission , Norges Bank , Capital International Investors , Citigroup , Free Report , Get Free Report , Exchange Commission , International Investors ,

© 2025 Vimarsana